Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 15,000 shares at $5.80 ($87,000)
  3. 4 Open-market buy Director bought 1,873 shares at an average $6.63 ($12,410)
  4. 4 Open-market buy Director bought 2,322 shares at an average $6.24 ($14,497)
  5. 4 Derivatives Options or other derivatives
  6. 4/A Open-market buy Director bought 10 shares
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Director bought 3,200 shares at an average $3.46 ($11,084)
  9. 4 Open-market buy Director bought 1,420 shares at an average $3.17 ($4,508)
  10. 4 Open-market buy Director bought 200 shares at $3.00 ($600)
  11. 4 Open-market buy President & CEO bought 1,000 shares at $2.00 ($2,000)
  12. 4 Open-market buy Vice President & CSO bought 1,000 shares at $2.00 ($2,000)
  13. 4 Open-market buy Director bought 5,000 shares at $3.00 ($15,000)
  14. 4 Open-market buy Director bought 200 shares at $3.00 ($600)
  15. 4 Open-market buy Director bought 200 shares at an average $3.10 ($620)
  16. 4 Open-market buy Director bought 900 shares at an average $3.33 ($2,999)
  17. 4 Open-market buy Director bought 2,480 shares at an average $3.53 ($8,752)
  18. 4/A Other acquisition Director acquired 89 shares (other)
  19. 4 Open-market buy Director bought 1,000 shares at $3.79 ($3,793)
  20. 4 Open-market buy Director bought 1,200 shares at $3.70 ($4,440)

Page 8 of 13 · 256 filings